Your email has been successfully added to our mailing list.

×
-0.00331103678929767 -0.0401337792642141 -0.0367892976588628 -0.0468227424749164 -0.0301003344481605 -0.0232107023411371 -0.0363545150501673 -0.0467892976588628
Stock impact report

Celsion shares rise 20% after FDA clears its ovarian cancer therapy for a phase 1/2 trial [MarketWatch]

Celsion Corporation (CLSN) 
Last celsion corporation earnings: 11/14 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.celsion.com/investor-relations
Company Research Source: MarketWatch
Celsion shares rise 20% after FDA clears its ovarian cancer therapy for a phase 1/2 trial Celsion Corp. CLSN, +9.93% shares rose nearly 20% in premarket trade Thursday after the company said the Food and Drug Administration had cleared its ovarian cancer therapy for a phase 1/2 clinical trial. The company plans to begin enrolling patients in the phase 1 part of the trial in the first half of the year, and expects to have a quarter of the study enrolled by the end of 2018. GEN-1 is a DNA-based immunotherapy for the local treatment of ovarian cancer. Celsion shares have plummeted 28.4% over the last three months, compared with a 6.9% rise in the S&P 500 SPX, +0.33% and a 10% rise in the Dow Jones Industrial Average DJIA, +0.45% Show less Read more
Impact Snapshot
Event Time:
CLSN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CLSN alerts
Opt-in for
CLSN alerts

from News Quantified
Opt-in for
CLSN alerts

from News Quantified